Sort
30,917 grants matching “tumor microenvironment”
The effects of PD-1 on tumor-mediated âemergencyâ myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity
$591,222Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA
The effects of PD-1 on tumor-mediated âemergencyâ myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity
$591,222Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2023 · CA
A platform to functionally sort and analyze tumor cells within combinatorial metastatic micorenvironments
$591,141David Kevin Wood · University Of Minnesota · R01 · FY2021 · CA
Targeted immuno-nanoparticles for directing antitumor immune response against breast cancer metastasis
$591,126Efstathios Karathanasis · Case Western Reserve University · R01 · FY2021 · CA
Targeted immuno-nanoparticles for directing antitumor immune response against breast cancer metastasis
$591,007Efstathios Karathanasis · Case Western Reserve University · R01 · FY2020 · CA
Pathology Core
$590,984Geoffrey I Shapiro · Dana-Farber Cancer Inst · P01 · FY2025 · CA
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis
$590,958Noula Dattu Shembade · University Of Miami School Of Medicine · R01 · FY2022 · CA
Angiogenesis and Tumor Growth
$590,925Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
preclinical optimization of BCMA directed T cell therapy
$590,784Marta Chesi · Mayo Clinic Arizona · R01 · FY2024 · CA
KSHV, HIV and the Kaposi's Sarcoma Tumor Niche
$590,775John T. West · University Of Nebraska Lincoln · R01 · FY2020 · CA
Neuronal MRGPR signaling in itch and allergic skin inflammation
$590,712Ethan A Lerner · Massachusetts General Hospital · R01 · FY2025 · AR
POTENTIATION OF ANTI-TUMOR IMMUNITY BY ONCOLYTIC VIRUS IN SITU VACCINATION
$590,392Dmitriy Zamarin · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
A novel paradigm of sensitization of the tumor microenvironment with image-guided ultrasound cavitation and mechanotherapeutics for targeted HCC treatment
$590,318Michalakis Averkiou · University Of Washington · R01 · FY2024 · EB
Targeting Glycogen Metabolism in Ewing's Sarcoma: Diagnostic, Prognostic, and Therapeutic Applications
$590,300Ramon C. Sun · University Of Florida · R01 · FY2025 · CA
Mechanisms promoting copper dependent cell death in cancer
$590,188Peter Tsvetkov · Broad Institute, Inc. · R01 · FY2023 · CA
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis
$590,138David B Agus · University Of Southern California · R01 · FY2013 · CA
Reprogramming the pancreatic tumor microenvironment with immunotherapy
$590,123Lei Zheng · Johns Hopkins University · R01 · FY2019 · CA
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$590,100Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2023 · CA
A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients
$590,031Ahmed Kaseb · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
A robust platform for multiplexed, subcellular proteomic imaging in human tissue
$590,000Robert Michael Angelo · Stanford University · UH3 · FY2019 · CA
Integrating bioinformatics into multiscale models for hepatocellular carcinoma
$589,905Elana Fertig · Johns Hopkins University · U01 · FY2019 · CA
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer
$589,881Carol Ann Lange · University Of Minnesota · R01 · FY2023 · CA
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer
$589,881Carol Ann Lange · University Of Minnesota · R01 · FY2022 · CA
Toward translation of a plant virus-based in situ vaccination nanotechnology
$589,872Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2024 · CA
Optimization of an active mutant KRAS peptide vaccine in colorectal cancer
$589,838Nilofer S. Azad · Johns Hopkins University · R01 · FY2025 · CA